Aclaris Therapeutics (ACRS) Gross Profit (2017 - 2026)
Aclaris Therapeutics' Gross Profit came in at $1.41 million for Q2 2026, up 11.8% from $1.26 million a year earlier but down 11.9% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Gross Profit (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Aclaris Therapeutics reported Gross Profit of $6.54 million, down 54.6% year-over-year; for FY2025, it was $5.74 million, down 64.0% from FY2024.
- Gross Profit carries a five-year compound annual growth rate of 33.6% (FY2020 to FY2025).
- Going back by year, Gross Profit was $15.93 million in FY2024 (-42.8%), $27.83 million in FY2023 (+8.2%), $25.73 million in FY2022 and $2.05 million in FY2021 (+51.8%).
- The five-year range for quarterly Gross Profit is $298,000 (Q1 2022) to $18.1 million (Q3 2022).
- Year-over-year, Gross Profit increased in two of the last eight quarters, with an average decline of 27.9%.
- The fastest year-over-year change in Gross Profit over five years came in Q1 2023 (growth of 477.2%), and the weakest in Q4 2025 (a decline of 91.0%).
- Business Quant data shows ACRS's Gross Profit at $1.6 million (Q1 2026), $763,000 (Q4 2025) and $2.76 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Aclaris Therapeutics | 735.48 Mn | 735.48 Mn | 1.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.41 Mn |
| Mar 31, 2026 | 1.60 Mn |
| Dec 31, 2025 | 763,000.00 |
| Sep 30, 2025 | 2.76 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 949,000.00 |
| Dec 31, 2024 | 8.51 Mn |
| Sep 30, 2024 | 3.69 Mn |
| Jun 30, 2024 | 2.14 Mn |
| Mar 31, 2024 | 1.59 Mn |
| Dec 31, 2023 | 16.85 Mn |
| Sep 30, 2023 | 8.43 Mn |
| Jun 30, 2023 | 827,000.00 |
| Mar 31, 2023 | 1.72 Mn |
| Dec 31, 2022 | 6.88 Mn |
| Sep 30, 2022 | 18.10 Mn |
| Jun 30, 2022 | 460,000.00 |
| Mar 31, 2022 | 298,000.00 |
| Dec 31, 2021 | 352,000.00 |
| Sep 30, 2021 | 560,000.00 |
API Access
Aclaris Therapeutics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();